These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21944463)

  • 1. Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer.
    Kang J; Chen MH; Zhang Y; Moran BJ; Dosoretz DE; Katin MJ; Braccioforte MH; Salenius SA; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e463-7. PubMed ID: 21944463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
    Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
    Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
    Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
    Krejcarek SC; Chen MH; Renshaw AA; Loffredo M; Sussman B; D'Amico AV
    Urology; 2007 Mar; 69(3):515-9. PubMed ID: 17382156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of diabetes and positive prostate biopsy in a US veteran population.
    Moses KA; Utuama OA; Goodman M; Issa MM
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):70-4. PubMed ID: 21894176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.
    Moreira DM; Anderson T; Gerber L; Thomas JA; Bañez LL; McKeever MG; Hoyo C; Grant D; Jayachandran J; Freedland SJ
    Cancer Causes Control; 2011 Jul; 22(7):977-83. PubMed ID: 21562753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
    Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
    BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
    Punglia RS; Cullen J; McLeod DG; Chen Y; D'Amico AV
    Cancer; 2007 Nov; 110(9):1973-8. PubMed ID: 17886252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and prostate cancer risk in the REDUCE trial.
    Wu C; Moreira DM; Gerber L; Rittmaster RS; Andriole GL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):326-31. PubMed ID: 21709690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?
    Abdollah F; Briganti A; Suardi N; Gallina A; Capitanio U; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):74-8. PubMed ID: 20956995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
    J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy.
    Albisinni S; De Nunzio C; Tubaro A; Barry WT; Banez LL; Freedland SJ
    Urology; 2012 Jul; 80(1):162-7. PubMed ID: 22608797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer.
    D'Amico AV; Braccioforte MH; Moran BJ; Chen MH
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1329-37. PubMed ID: 19879061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
    Pinsky PF; Andriole G; Crawford ED; Chia D; Kramer BS; Grubb R; Greenlee R; Gohagan JK
    Cancer; 2007 Apr; 109(8):1689-95. PubMed ID: 17330856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
    Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
    Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
    Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
    Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
    Nanda A; Chen MH; Renshaw AA; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.